Takeda Pharmaceutical Company Continues Global R&D Reboot, Enters JV With PRA Health

PRA Health Sciences (NASDAQ:PRAH) has entered into a joint venture with Takeda Pharmaceutical Company Limited to further globalize Takeda’s development business in Japan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.